There are already 3 in the bed, which is kinky enough....KD and HL and Donny.

Accepting BKC's analysis of the balance sheet Resverlogix has enough cash to last through the next 12 months. And remember, KD and HL didn't buy their shares on the open market, they provided direct funding to the company in exchange for shares and warrants.

If a big buyer is lurking, the money they would be investing in the purchase of shares of RVX....that $$$ wouldn't be going into the comany's coffers to fund further operations in 2017 and beyond.

If/when (although it seems more likely a case of when) RVX needs more funding to keep the lights on....then we'll see what route they go. Would the likes of KD and HL be willing to pony up more cash? Perhaps a secondary offering underwritten by a large house?

I reference Ziopharm because I've done research on it and know it fairly well.....In October of 2014 their PPS was languishing down around $2.....they partnered with MD Anderson out of Texas, but had to pay them $57.5 million large. Problem is they didn't have the capital, so they gave it to them in shares....$50 million worth to sign the deal, and another $7.5 million to get in done in time for a JP Morgan investor dog and pony show. Then in February they announced a secondary and the herd stormed in and bought it up like made....driving the PPS from that $2 area in October up to near $15 just a few months later.

Lots of things can happen, but another HL or KD stepping up at this juncture doesn't concern me at all.